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Abstract
This paper analyzes the impact of a firm’s external financial environment and the feature
of its investment projects on the firm’s boundary and ownership structure. Our theory
highlights the costs of a full ownership over an asset in destroying the owner’s commit-
ment capacity. More specifically, if a firm finances a risky R&D project jointly with other
financiers, informational asymmetries and conflicts of interest among co-financiers can be
used as a commitment device to stop a bad project when it is discovered; but such a com-
mitment would be lost if a firm choose to own and finance a project. Trading the costs of
full ownership with those of a partial ownership through joint financing, which depend on
the external financial environment, large firms in a developed financial environment opti-
mally choose to a full ownership of less risky R&D projects. In an underdeveloped financial
environment, however, joint ownership is often too costly to be chosen regardless the risk
level of R&D projects.
1We thank Masahiko Aoki, Patrick Bolton, Leonardo Felli, Charles Goodhart, Oliver Hart, John Moore,
Mark Schankerman, John Sutton and participants of a CEPR conference on internal capital market (Naples)
for helpful discussions; Jian Tong for research assistant; and Nancy Hearst for editorial help. In particular,
we thank Eric Maskin for comments and advice on this project. All remaining errors are our own.
1
1. INTRODUCTION
What determines the boundary of a firm when research and development (R&D) is in-
volved? More specifically, if a R&D project is closely related to a large firm’s business,
should this firm own the R&D project or contract it out? This question is closely related
to the question raised by Coase (1937): What determines the boundary of a firm? A great
deal of theories have been developed to address this question.2
The question raised by Coase is based on observations that a large number of transactions,
which seemingly can be traded efficiently in markets (by applying standard price theory),
are carried out within a firm. Here, our observation is that there are many cases in which
integrating a R&D project to a large-firm may seem to be more desirable (by applying
theories of the firm and/or of information) yet this firm chooses to not to. In this paper, we
analyze what affects a large firm’s decision on wether or not to integrate a R&D project.
More specifically, we identify conditions under which a large firm prefers to integrate a
R&D project — to finance it internally; and those conditions under which the firm prefers
to finance the project externally and jointly with other financiers.
The question we raise in this paper is motivated by several stylized facts and is in-
spired by the existing theories of the boundary of the firm and of R&D financing. It is
documented that large corporations tend to restrict their internal R&D activities in less
uncertain and less novel projects that they devote more attention to perfection-related
or cost-reduction-related innovation and less attention to new-product-related innovation
(Scherer, 1991, 1992); they often choose not to integrate high-uncertain R&D projects
but finance them as stand-alone small firms jointly with other financiers.3 Consistently,
2See Hart (1995) and Holmstrom and Roberts (1998) for recent surveys.
3A typical externally financed small high-tech firm has several investors, such as corporate and inde-
pendent venture capitalists and others. Based on a sample of 271 biotech firms, Lerner (1994) reports
that syndication is common in all rounds of investments and the average number of investors in the first
round of investment is about 3 (the number is further larger in later stages). Schilit reported that most
venture capital firms syndicate with one another, and that between 70% and 90% of the venture capital
backed projects had multi-investors (Schilit, 1991, pp.76-77). Barry et al. (1990) reported that all 433
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“idea-rich small firms originate a disproportionate share of innovations” (Scherer, 1992).4
This is particularly true in high-tech industries, such as in bio-tech,5 and the computer,
telecommunications industries.6
Applying the theory developed by Grossman and Hart (1986) and Hart and Moore (1990)
to the question, if a R&D project is complementary to the core business of a large firm,
then it is efficient for the project being integrated with the firm. Moreover, Schumpeter
argued that by integration large corporations can be more efficient in innovation because
venture-capital-backed firms which had initial public offerings between 1978 and 1987 in the U.S. (this is an
exhaustive data set for this category) had many investors, including venture capitalists (VC), large firms,
and other funds. A typical firm in this data set involved three venture capital investors; and had two VCs
sat on its board (accounted for one-third of all seats). A survey of venture capital in New England (one
of the two areas in the U.S. with the highest VC concentration), shows the average number of investors for
each high-tech start up firm (more than one half of which were in bio-tech) was close to four, and only about
one-eighth of the surveyed firms were financed by one investor (Boston Globe, September 19, 1993).
4 In the United States, firms with 500 employees or less accounted for about 40 percent of all technical
innovations in manufacturing in 1982 (Acs and Audretsch, 1988). A majority of the 100 most important
innovations during the 1900-1950 period were introduced by small firms (Jewkes, et al., 1969). Among 21
major software, 18 originated in small start-up firms, although the best-selling software was marketed by
large established firms (Prusa and Schmitz, 1991).
5 In 1994, 1995, and 1996, Merck, the best performing large pharmaceutical company (in terms of Dow
performance) in the US spent $1.2 billion, $1.3 billion, and $1.5 billion respectively for R&D; and respectively
developed 10, 8, and 8 new drugs (in late-stage clinical trials). In contrast, small firms achieved more than
Merck at far lower costs. In those years, 130 publicly traded small bio-tech companies in the U.S. spent $3.1
billion, $3.4 billion, and $3.9 billion; and respectively developed 60, 100, and 220 new drugs (Fortune, No.
6, March 31, 1997).
6An overwhelmingly large majority of today’s major computer companies, such as Intel, Microsoft, Apple
Computer, Digital Equipment, Compaq Computer, Lotus Development, and Sun Microsystems were all
small firms and were financed by outside investors (including corporate venture capital, independent venture
capitalists, and many other sources) in the 1970s and the 1980s. However, the amount of R&D investment
and capital expenditures in all of these small firms together was less than that in one large firm. For example,
in 1988 IBM’s investment for R&D and capital expenditures was about $9 billion, while in the same year the
total investment for R&D and capital expenditures from U.S. professional venture capitalists to small firms
in all industries, including computer and bio-tech industries, was only about $3 billion (Sahlman, 1990).
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they have the wealth to provide internal funds (Schumpeter, 1950).7 Consistently, it has
been well argued that the informational asymmetries related to external financing can make
an investment more costly due to moral hazard and adverse selection problems between the
entrepreneur and the financiers (e.g., Stiglitz and Weiss, 1981; Myers and Majluf, 1984;
and Kamien and Schwartz, 1978). Furthermore, given that a R&D project involves a large
sunk cost (low liquidation value), with external financing the moral hazard and adverse
selection problems are more severe (Bernanke and Gertler, 1989; Calomiris and Hubbard,
1990; Hubbard and Kashyap, 1992). Then the question is, if a large-firm is not constrained
by wealth to self-finance a R&D project which is complementary to its core business,8 why
should it ever choose to finance R&D projects externally?
In this paper we provide a theory to link the boundary of a firm to its external finan-
cial environment and the feature of R&D projects. We argue that the optimal allocation
of a firm’s boundary depends on the external financial environment and the features of
R&D projects. In our theory, we suppose that the uncertainties associated with an R&D
project can only be reduced when the project is carried out. Therefore, ex-post selection
is more effective than ex-ante selection. However, an ex-post screening mechanism requires
a commitment that a bad project will be stopped even when refinancing the bad project
is ex-post profitable (which means that the earlier sunk costs of the project are not taken
into consideration in an ex-post decision). We show that non-integration, in which a firm
finances a project externally with other financiers, can be deployed as a commitment device
7Obviously he changed his early view about small firms’ advantages in originating innovations late on
(Schumpeter, 1934).
8 Indeed, the micro-processor and the operating system are complementary to the IBM PC, and IBM
had the financial capacity to finance the related R&D. But IBM contracted out all the micro-processor
and operating system R&D projects to Intel and Microsoft in the 1970s when they both were small firms.
Moreover, in general, large firms are not wealth constrained in financing R&D projects internally. Several
independent investigations find that for large firms, such as Fortune 500 firms, there is no correlation between
internally financed investments and R&D (Scherer, 1965; Mueller, 1967; Elliot, 1971), or there is a very low
correlation (Hall, 1992). Consistent with these results, more recent work finds that the larger the firm, the
lower the correlation (Himmelberg and Petersen, 1994).
4
for a large-firm to terminate bad projects when they are discovered ex post.9 With an inte-
gration, however, a large firm may loss this commitment capacity. That is, there is a cost
of possessing a full ownership over a R&D project, which is the owner’s loss of commitment
capacity. Moreover, the more uncertain a R&D project, the larger is the cost of integration.
Therefore, the allocation of the boundary of a firm is determined by the trade-off between
the efficiency gain from solving the commitment problem – gaining the capacity to make
ex-post selections – and the institutional cost of external financing. Here, the institutional
cost of external financing refers to those moral hazard and adverse selection problems which
have been extensively discussed in the literature. As a result of this trade-off, if a project is
relatively certain, integration, i.e., internal financing, is more efficient; if a project is more
uncertain, non-integration, i.e., external financing, is more efficient.
Our theory is built upon Dewatripont-Maskin model (1995) of soft budget constraints
(a la Kornai, 1980), which is centered on an institution’s lack of commitment to terminate
an unprofitable project ex-post. We provide a new contractual foundation for hardening
budget constraints that investors are not constrained by the liquidity of wealth to finance a
project alone if they so choose. The new contractual foundation allows us to expand the soft
budget constraint paradigm to the issue we address in this paper, and many other issues
which we briefly discuss in the conclusion of the paper.
In the spirit of Hart and Moore (1995) and Bolton and Scharfstein (1996), conflicts of
interest between the multi-investors play important roles in our model. However, we focus
on the commitment problem and endogenize a renegotiation-proof institution.
Our theory also sheds light on syndicated financing. It is documented that “syndicated
loan market [is] not only one of the largest, but also one of the fastest growing sources
of corporate financing available today” and “the market has been growing at a compound
9It has been documented that informational asymmetries and conflicts of interest between co-investors
increase the ex post cost of refinancing a project and destroy value when a firm is under re-organization
(e.g., Weiss and Wruck, 1998; for a court case regarding converting a reorganization into liquidation due
to conflicts of interest between investors, see U.S. Bankruptcy Court for the Western District of Michigan,
1997).
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annual rate of more than 10% per year over the last decade.” In year 2000 banks extended
$2 trillion of syndicated loans (Esty and Megginson, 2001) — in contrast the total amount
of loans and leases in bank credit in the U.S. in the same year was $3.88 trillion and the
total value of bank assets was about $6 trillion. [In reality as long as there are several
financiers involved and they have different specializations, then their informa-
tion and interests are naturally different. According to Esty and Megginson
(2001), Our theory also helps to explain the paramount importance of such a
financial phenomena from a theoretical perspective.10]
Our theory complements to a recent literature on R&D financing that studies the is-
sue from the perspective of knowledge transfer (e.g., Allen and Gale (1999); Bhattacharya
and Chiesa (1995)). This strand of literature concernes about difficulties in transferring
knowledge and looks for ways to make knowledge transfer easier. Our theory argues about
different side of an informational asymmetry between co-financiers that difficulties in knowl-
edge transfer can be benefitial to financiers in helping termination of bad R&D investment
promptly.
The rest of the paper is organized as follows. In Section 2 we set up the model. In
Section 3 we endogenize the commitment problem in integration and find a solution for the
commitment problem in non-integration. Section 4 compares the efficiencies of integrated
and non-integrated R&D. Finally, Section 5 discusses the conceptual implications of our
results for economic growth and financial crisis, and presents some concluding remarks.
10One can easily see the paramount importance of syndicated loans as a financial phenomenon if the
amount of syndicated loans ($2 trillion of in 2000) is compared with the total amount of loans and leases in
bank credit in the U.S. ($3.88 trillion, December 2000).
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2. MODEL
We consider an economy where there are numerous entrepreneurs and large-firms.11 Each
entrepreneur has a new idea for an R&D project, but he has no wealth to finance it. There
is no wealth constraint on the side of the large firm to finance R&D projects. When an
entrepreneur proposes a project to a large-firm, if the firm is interested in the project it can
choose to either integrate the project by purchasing the project and hiring the entrepreneur
— finance it internally, or to not integrate it but finance it externally and jointly with others.
We suppose that among all the projects proposed by entrepreneurs, λ percentage of them
are a good type and 1 − λ percentage of them are a bad type. A good project takes two
periods to finish and requires a total investment of I1+I2, where It is the required investment
in period t and I1 and I2 are sunk.12 And a good project is profitable, bV > I1 + I2. A
bad project produces no return after second period. But it can be reorganized in the third
period and the reorganization costs I3. Thus, it takes three periods for completion and
requires a total investment of I1 + I2 + I3.
Because a good project will be completed at date 2 regardless of integration or non-
integration. Thus, from the perspective of financing decision there is no difference between
different ownership cases. In the rest of the paper, we will focus on the case of bad projects.
We suppose that the returns from a completed bad project under the best possible reorga-
nization strategy generated at date 3 can be greater than those of the last period investment,
however, it is not efficient to be undertaken after date 1. Therefore, at date 2 a decision
has to be made by the financier(s) regarding a bad project: either to refinance it or to
liquidate it. To focus on this point, we suppose that at date 0 all projects are worthy of
11 In this paper we do not distinguish between large firms and financiers in general (e.g., independent
venture capitalists). We suppose that each financier has enough wealth to finance R&D projects. In fact, a
major source of financing R&D is corporate venture capital which finances external projects for the benefit
of the patent corporation (e.g., Schilit (1991, p.68)). Moreover, the venture capital subsidiaries of large firms
have “deep pockets.”
12We can regard zero as a normalized liquidation value. Our results will not be altered if we allow I1 and
I2 to be partially sunk and the liquidation value to be positive.
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being financed, and we assume that the discount rate is zero.
With respect to information, we assume that ex-ante the distribution of the types of
all projects is common knowledge, but neither the large firms nor the entrepreneurs know
precisely each project’s type. At date 1, after working on a project for one period the
entrepreneur discovers the type of the project, but the large firm(s) still do not know its
type. That is, there is an informational asymmetry between the entrepreneur and the
large-firm(s) at date 1.13
We suppose that an entrepreneur receives a private benefit bt from working on a project,
where t = 1, 2, 3 denotes the date when the project is either completed or terminated.
Specifically, if the entrepreneur quits the project at date 1, he gets a low private benefit,
b1 > 0. At date 2, a completed good project generates a private benefit, b2g > b1, to the
entrepreneur. A bad project will not generate any outcome at date 2 and it will be either
liquidated or reorganized. If it is liquidated, the entrepreneur gets a still lower private
benefit b2b, where 0 ≤ b2b < b1. If a bad project is reorganized, it will be completed at
date 3 without costs the entrepreneur’s effort. A completed bad project generate a private
benefit b3 ∈ (b1, b2g), and b3 > b2g.14
Presumably, there are two strategies to reorganize a bad project during the third period,
but only one of them can generate a profit ex-post. The selection of the right decision
depends on signals sA and sB, where sJ ∈ [s, s], s < s and J = A, B. Here, we suppose
that signal sJ can only be observed by the financier after I3 is invested.15
In the simplest case, we look at a case that A wishes to find a co-financier B to be a
commitment device to co-finance a project (or similarly, B looks for A who has a different
specialization from that of B). Then the following are the conditions that joint financing by
13This assumption is realistic because a R&D project is something new so other agents can only know its
features later than the entrepreneur who works on it.
14The relationship b3 > b2g can be regarded as a reduced form of the following relationship: suppose
completing a good project at date 2 requires more efforts than completing a bad project at date 3; and the
cost of the additional efforts is e such that b3 > b2g − e.
15The assumption that sJ can only be observed after I3 is invested is not essential in the model. Its role
is to rule out mixed strategies, which would complicate the model without providing more insight.
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A and B can serve a commitment purpose. These conditions concern how reorganization
strategies are related to information sA and sB. First, A is specialized in technology A,
and B is specialized in technology B, such that A can only observe sA and B can only
observe sB.16 Second, the relationship between A and B satisfies the following efficiency
condition (A-1.1): strategy b makes the project ex-post profitable if the value of signal sA
is higher than the value of sB; and strategy a makes the project ex-post profitable if the
value of signal sA is lower than that of sB. Formally,⎧
⎪⎪⎨
⎪⎪⎩
V bA(sA, sB) + V
b
B(sA, sB) > I3 > V
a
A(sA, sB) + V
a
B(sA, sB), if sA > sB;
V bA(sA, sB) + V
b
B(sA, sB) = V
a
A(sA, sB) + V
a
B(sA, sB) = I3, if sA = sB;
V aA(sA, sB) + V
a
B(sA, sB) > I3 > V
b
A(sA, sB) + V
b
B(sA, sB), if sA < sB.
(A-1.1)
16There are many ways to justify or to endogenize the information asymmetry between A and B after
date 3. One possible way is the following. Suppose, for each project, there are two signals, s¯A and s¯B , on
different aspects of the project that can be observed by the financiers in the first two periods. If the two
signals s¯A and s¯B are observed by the financiers, they will receive a positive profit from a good project, i.e.,bV > I1 + I2 (e.g., through financing the R&D project large firms intend to use the technology developed by
the project, thus the information). Without the information, the investors will get a positive but smaller
return. With their specialities, financier A can observe s¯A with no costs, but has to pay a cost cA (e.g., to
hire a consultant) to observe signal s¯B ; and vice versa. Therefore, if the two financiers decide to syndicate
their investments in an R&D project, they can collect s¯A and s¯B without incurring costs. However, in the
case of internal financing, the large firm has to pay the cost to get information about which the firm is not
specialized. We suppose that signal sJ can only be observed by the investor who has observed s¯J earlier, after
I3 is invested. Another way to generate the informational asymmetry is if there is an item in the contract, or
there are some other reasons, which prevents the co-financiers from sharing information. In the following we
provide a hypothetical case to illustrate how different specialities of two financiers can generate asymmetric
information between them. For example, IBM and Kodak might have interests to co-finance a R&D project
for a new type of memory chip which might have a great impact on the development of computers and digital
cameras (similarly, several large pharmaceutical companies may have an interest in co-finance a new bio-tech
project which may have a revolutionary impact on diabetes or cancers drugs). Due to their idiosyncratic
interests and specialties, IBM and Kodak may draw different information from the same project. Similar
illustrations may also be provided for the case of multiple specialized financial institution co-financing, such
as co-financing provided by different venture capital firms specializing in various technologies (such as alliance
between biotechnology and pharmaceutical firms as studies by Lerner and Merges (1998)); or co-financing
provided by venture capital firms, large firms, or mutual funds, etc.
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where V jJ (sA, sB) is the payoff of the reorganized project enjoyed by large firm J when strat-
egy j is taken, and j = a or b and J = A or B.17
Moreover, the relationship between A and B satisfies the second efficiency condition
(A-1.2): the outcome of a wrong strategy is bad enough that the expected net payoff of
randomizing between the two strategies is worse than liquidation, i.e.,
qV b(sA, sB) + (1− q)V a(sA, sB)− I3 < 0 (A-1.2)
where, V a(sA, sB) = V aA(sA, sB) + V
a
B(sA, sB), V
b(sA, sB) = V bA(sA, sB) + V
b
B(sA, sB) and
q = Pr(sA > sB).18
Finally, the two co-financiers A and B have a conflict of interest (condition (A-2)) in
choosing reorganization strategies. In the case that the value of sA is higher, it is more
beneficial to financier A if the project is reorganized under strategy a than under strategy
b; and vice versa. This condition implies that each financier J has an incentive to use
strategy j if their own signal value becomes higher. That is, for any sh > sl,
V aA(s
h
A, sB)− V aA(slA, sB) > V bA(shA, sB)− V bA(slA, sB) > 0, (A-2.1)
V bB(sA, s
h
B)− V bB(sA, slB) > V aB(sA, shB)− V aB(sA, slB) > 0. (A-2.2)
In the following we provide an example to illustrate that above assumptions are relevant
to real life business.
Example: Suppose a project is to develop a revolutionary gene-therapy-based drug for a
broad range of heart diseases. Financier A is specialized in traditional drugs in heart diseases
(e.g. a large pharmaceutical company) and has access to information on marketing/retailing
this type of drug esA. Financier B is specialized in evaluating gene-therapy technology (e.g.
a venture capitalist specialized in the field) and has access to information on cost of gene-
therapy products esB. Thus, if A finances the project alone (e.g. a large firm purchases
the R&D project), then A will collect esA without cost and esB with extra costs (e.g. cost
17We can relax assumption (A-1.1) so that if signal sA is higher than sB, strategy b always makes the
project more profitable ex post than strategy a and some times only strategy b makes the project profitable
ex post; and vice versa. In so doing, our results would not be affected qualitatively.
18Any randomization based on eq ∈ [0, 1] and eq 6= q cannot get a better result than (A-1.2).
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of hiring experts). If A and B finance the project jointly, A and B will gather relevant
information based on their expertise without extra cost. If the project is a good one it will
be completed at date 2 regardless weather it is financed by A alone or jointy by A and B.
In the case that the project is a bad one, existing reorganization strategies are the following:
strategy a — replacing the pure gene-therapy-based approach with a mixed technology (e.g.
a technology mixed between gene-therapy approach and traditional ones); or strategy b —
narrowing down the application target to a smaller range of heart diseases while keeping
the pure gene-therapy technology. Which reorganization strategy makes the project ex-post
efficient depends on the demand for the potential new drug — signal sA; and the cost of
producing the potential new drug — signal sB. Moreover, sA and sB will be learned based
on knowledge of esA and esB. If sA > sB (the revenue generated by the demand from
some heart disease patients is higher than the cost of producing the drug by using related
gene-therapy technology) then strategy b is efficient. Otherwise, strategy a is efficient to
reduce cost of new drug. In this example, we suppose that q = 0.7 and I3 = 109. The other
parameter values and corresponding payoffs are shown in the following table.
slA case
shA case
signal sA signal sB payoff V aA payoff V
b
A payoff V
a
B payoff V
b
B
0.6 0.4 40 45 40 65
0.7 0.4 48 47 40 65
It is easy to see that condition (A-1.2) is satisfied; and given sA > sB in both cases, applying
condition (A-1.1) strategy b is ex post efficient.
Given the above conditions, if a project is externally co-financed, ex-post if the co-
financiers want to reorganize a bad project, they need to find a scheme to share their
private information. This is equivalent to saying that B needs to find a scheme to buy sA
from A, or vice-versa. Without a loss of generality, B will buy the private information sA
from A only when the price that B has to pay, T (sA, sB), is not too high.
Now we summarize the timing of the game as follows:
• Date 0: All parties know the distribution of the projects but no one knows which
project is good and which project is bad. The large-firm(s) offer a take-it-or-leave-it
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contract to the entrepreneur. If the contract is signed the large firm(s) will invest I1
units of money into the project during period 1, and the large-firm(s) will start to
observe s¯A and s¯B.
• Date 1: By working on the project, the entrepreneur becomes aware of the type of the
project, but the large firm(s) still does not know the type. If the entrepreneur stops
the project he gets a private benefit b1 > 0; otherwise, if the project is continued, I2
units of investment are required from the large firm(s).
• Date 2: The type of project becomes public knowledge:
— If the project is a good type, it will be completed on date 2 and will generate
a return of bV to the large firm after the large firm observes s¯A and s¯B; and a
private benefit of b2g > b1 to the entrepreneur but costs him e > 0;
— if it is a bad project, a decision whether or not to liquidate or to reorganize has
to be made.
∗ If the project is liquidated the large firm(s) get(s) zero and the entrepreneur
gets b2b < b1; otherwise,
∗ if the project is reorganized, I3 units of investment are required.
• After investing I3, signals sA and sB are observed by the large firm(s) and a reorga-
nization strategy is chosen based on the signals.
• Date 3: A bad project is completed and generates a return of V to the large firm(s)
and a return of b1 < b3 < b2g to the entrepreneur.
3. REFINANCING DECISIONS
Given that refinancing a (bad) project after date 2 is ex-ante inefficient, only those insti-
tutions that are able to commit to stopping bad projects are efficient in dealing with highly
uncertain innovative projects. In this section, we show that non-integration, i.e., external
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co-financing, provides a commitment device to stop bad projects but integration does not
have the commitment device.
3.1 Non-integration
We start with the co-financiers’ refinancing decision at date 2 and then consider the
entrepreneur’s investment decision at date 1. At date 2, when the two financiers discover
that the project is a bad one, they should decide either to liquidate or to reorganize (i.e., the
financiers assign a probability of p to refinance the project19). If they decide to reorganize
the project, they will invest I3. Then signals sA and sB are observed by the two financiers
respectively and they need to decide what reorganization strategy should be selected (i.e.,
the financiers assign probabilities of 1 − q(sA, sB) and q(sA, sB) to use reorganization
strategy a and b respectively).
We now show that the asymmetric information between the two financiers will make
refinancing ex-post inefficient, thus they will terminate bad projects at date 2.
Proposition 1 Under assumptions (A-1) and (A-2), under non-integration all bad projects
are liquidated at date 2.
Proof. We show that if financier J is able to observe only sJ (J = A or B) after I3 is
invested, under (A-1) and (A-2) there is no efficient incentive compatible scheme q(sA, sB)
and T (sA, sB) which can induce financier J to tell the true value of sJ ; thus there is no
efficient scheme to reorganize the project. As a result, the financiers choose to liquidate
the bad project.
In the following proof, we first analyze financier A’s incentive problem. For this purpose,
we fix sB at an arbitrary value s∗ ∈ (0, 1).
Given compensation scheme T (sA, sB) and strategy q(sA, sB), financier A should tell the
truth only if the expected payoff of doing so is not worse than false reporting. That is, the
19For example, if their decision is to definitely liquidate the project, they assign p = 0.
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incentive compatibility (IC) condition is:
q(sA, sB)V bA(sA, sB) + (1− q(sA, sB))V aA(sA, sB) + T (sA, sB)
≥ q(bsA, sB)V bA(sA, sB) + (1− q(bsA, sB))V aA(sA, sB) + T (bsA, sB),
where bsA is the false report of the signal.
In the case that the information sA = shA > s
∗, the IC is
q(shA, sB)V
b
A(s
h
A, sB) +
³
1− q(shA, sB)
´
V aA(s
h
A, sB) + T (s
h
A, sB)
≥ q(slA, sB)V bA(shA, sB) +
³
1− q(slA, sB)
´
V aA(s
h
A, sB) + T (s
l
A, sB),
that is,
T (shA, sB)− T (slA, sB) ≥
³
q(slA, sB)− q(shA, sB)
´
V bA(s
h
A, sB) +³
q(shA, sB)− q(slA, sB)
´
V aA(s
h
A, sB). (1)
The IC for A’s information sA = slA < s
∗ is:
q(slA, sB)V
b
A(s
l
A, sB) +
³
1− q(slA, sB)
´
V aA(s
l
A, sB) + T (s
l
A, sB)
≥ q(shA, sB)V bA(slA, sB) +
³
1− q(shA, sB)
´
V aA(s
l
A, sB) + T (s
h
A, sB),
that is, ³
q(slA, sB)− q(shA, sB)
´
V bA(s
l
A, sB) +
³
q(shA, sB)− q(slA, sB)
´
V aA(s
l
A, sB)
≥ T (shA, sB)− T (slA, sB). (2)
The IC conditions (1) and (2) imply³
q(slA, sB)− q(shA, sB)
´
V bA(s
l
A, sB) +
³
q(shA, sB)− q(slA, sB)
´
V aA(s
l
A, sB)
≥
³
q(slA, sB)− q(shA, sB)
´
V bA(s
h
A, sB) +
³
q(shA, sB)− q(slA, sB)
´
V aA(s
h
A, sB),
or, ³
q(shA, sB)− q(slA, sB)
´³
V aA(s
h
A, sB)− V aA(slA, sB)
´
≤
³
q(shA, sB)− q(slA, sB)
´³
V bA(s
h
A, sB)− V bA(slA, sB)
´
.
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According to (A-2.1), V aA(s
h
A, sB) − V aA(slA, sB) > V bA(shA, sB) − V bA(slA, sB) > 0. Thus,
the incentive compatibility implies q(shA, sB) ≤ q(slA, sB), i.e., q(slA, sB) should be non-
increasing in sA.
However, by (A-1), for any given sB when sA increases from sA < sB to sA > sB, for any
q(sA, sB) = q¯, where q¯ ∈ [0, 1) is a constant, the efficiency can be improved by increasing
q¯, i.e. by q¯+ ε, where ε > 0. Thus, the efficiency requires q(sA, sB) to be non-decreasing in
sA.
Therefore, the only possible scheme of q(sA, sB) which may satisfy both IC and the
efficiency requirement is to keep q(sA, sB) constant, i.e., q(sA, sB) = q¯. It is obvious that
for any q¯ ∈ [0, 1], reorganization based on any q¯ 6= q = Pr(sA > sB) is worse than q.
However, by (A-1.2), a reorganization decision based on q is worse than liquidation.
The case of financier B can be proven by symmetry.
Given the above results, any randomization between liquidation and reorganization at
date 2 will be worse than liquidation. Thus, the probability of liquidation is 1− p = 1.
The intuition behind this proposition is the following. The incentives of A lead to
a condition that for any given value of sB, the higher is the value of sA, the less likely
strategy b should be used. However, the efficiency condition (A-1.1) implies that for any
given value of sB, the higher is the value of sA, the more likely strategy b should be used.
The only reconciliation between these two conditions is to keep the probability of using
strategy b independent from signal sA, but the efficiency condition (A-1.2) says that this
kind of reorganization will incur losses ex-post, thus it is worse than liquidation.
In the following we use the same example to illustrate how the commitment mechanism
of external co-financing works.
Example (continued):Given the parameters that I3 = 109 and
slA case
shA case
signal sA signal sB payoff V aA payoff V
b
A payoff V
a
B payoff V
b
B
0.6 0.4 40 45 40 65
0.7 0.4 48 47 40 65
only strategy b is ex post efficient for both cases. However, when sA increases from slA to
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shA, A
0s payoff increases more if strategy a is used than that of strategy b (condition (A-2)).
Thus, A has an incentive to under report sA to increase the chance that strategy a will be
used. This is the critical condition that drives the result of Proposition 1.
This proposition says that when a bad project is revealed to the large firm at date 2,
there exists no efficient reorganization scheme which can be agreed upon by both financiers.
That is, as a result of the informational asymmetry and conflicts of interest between the
two financiers, external co-financing can serve as an ex-post commitment device to stop
bad projects. This insight is consistent with the insight of Maskin (1992) in the context
of auction with private information in that an information asymmetry between two parties
can make auctions inefficient.
This commitment to liquidate bad projects has a deterrent effect on entrepreneurs who
have bad projects. Afraid of further losses by hiding bad news, an entrepreneur with a bad
project will choose to quit once he discovers it is a bad one because the losses incurred by
quitting at date 1 are smaller than those at date 2, i.e., b2b < b1. To summarize, we have
the following result:
Corollary 1 Under external co-financing, entrepreneurs are induced to stop bad projects
at date 1 but not a good project.
The model sheds light on syndicated financing. In reality as long as there are several
financiers involved and they have different specializations, then their information and in-
terests are naturally different. That is, the fact that conditions (A-1) and (A-2) are likely
satisfied, even without financiers’ prior knowledge of any details about these conditions,
helps financiers to stop bad projects promptly. Given that banks extended $2 trillion of
syndicated loans in 2000 (Esty and Megginson, 2001), our theory also helps to explain the
paramount importance of such a financial phenomena from a theoretical perspective.
R&D financing and the boundary of the firm has also been studied from the perspective of
knowledge transfer (see Allen and Gale (1999) and Bhattacharya and Chiesa (1995), among
others). This strand of literature is concerned about difficulties in transferring knowledge
and tries to make knowledge transfer possible. Our theory provides a complementary the-
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oretical answer, which argues that an informational asymmetry between co-financiers that
prevents a knowledge transfer can also have benefits to financiers, because if used wisely,
the difficulty in knowledge transfer can stop bad R&D investment promptly.
3.2 Integration
We again begin our analysis with the refinancing decision at date 2 and then consider
the entrepreneur’s investment decision at date 1. Under integration, a project is internally
financed. In that case, the large firm will have all the information sA and sB and will be
able to use this information to choose an ex-post efficient strategy to reorganize the project
such that payoff V ∗(sA, sB) is greater than the ex-post cost of refinancing, I3. Therefore,
the firm is not able to commit to terminating a bad project ex-post.
Moreover, the fact that the large firm cannot commit to terminating a bad project affects
the entrepreneur’s ex-ante incentives to reveal information. When the entrepreneur at date
1 discovers that his project is a bad one, he expects that the project will always be continued
and refinanced by the financier at date 2. Consequently, if he quits the project, he gets
private benefit b1; if he continues the project, the bad project will always be refinanced by
the financier and will generate a private benefit b3 > b1 for the entrepreneur.
Proposition 2 Under assumption (A-1), at equilibrium a financier does not reward an
entrepreneur to reveal the type of a project at date 1 and does not liquidate bad projects at
date 2. As a result bad projects are always re-organized by the single financier.
Proof. When a project is financed by a single financier, the financier will have all the
information sA and sB and will be able to use this information to choose an ex-post efficient
strategy to reorganize the project such that payoff V ∗(sA, sB) is greater than the ex-post
cost of refinancing, I3. Therefore, when the financier leans the bad type of a project at date
2, given that earlier investments are sunk and V ∗(sA, sB) > I3, the financier will chose to
reorganize a bad project.
However, when the entrepreneur at date 1 discovers that his project is a bad one, he
expects that the project will be continued by the financier at date 2 and anticipates a
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private benefit b3 > b1. Therefore, the entrepreneur will choose not to tell the type of a
project if it is bad. In the following we show that at equilibrium the financier will choose
not to reward the entrepreneur to reveal the project type at date 1.
Suppose a financier offers a reward, τ , to an entrepreneur at date 1 to induce him to
tell the type of a project. There are several possible reward schemes: τ1 ≥ b3 − b1; τ2 ∈
(b2g − b1, b3 − b1); τ3 < b2g − b1. Given b1 < b2g < b3, under the reward τ1 an entrepreneur
will report all project as bad ones in order to collect the reward and the financier is not
able to verify the truthfulness from projects stopped at date 1. If the reward is set at τ2
the entrepreneur will report good projects as bad ones to collect the reward; and will report
bad projects as good ones since by doing so a bad project will be continued. If the reward
is τ3 an entrepreneur will report all projects as good ones anticipating continuation of bad
projects. However, for the financier no reward is the cheapest for the same outcome of τ3.
Obviously no reward dominates τ1,τ2 and τ3.
An interesting insight from this result reveals that without conflicts of interest and in-
formational asymmetries on the financier side, single financier financing is not able to solve
the asymmetric information problem between the financier and the entrepreneur due to the
lack of commitment to liquidate bad projects.20
Our model can be interpreted broadly. A key to the model is the number of agents
who collect information and make the reorganization decision. There are many different
institutions corresponding to our model of integration, that is they are featured by single
agent coordinated financing. Examples include ‘main-bank’ coordinated financing in Japan,
government-coordinated financing in South Korea, or a centralized economy, where the state
bank (or the government) finances all the projects and collects all the information.
20This result is similar to that of Dewatripont and Maskin (1995). The major difference between their
result and ours is that there is no wealth constraint on the investors in our model; moreover, in our model
the two investors are involved simultaneously, while in their model the investors are involved sequentially.
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4. EFFICIENCIES
The above section shows the benefits associated with non integration or external co-
financing. However, there are extra costs associated with non integration relative to inte-
gration or internal financing. The asymmetric information between a start-up firm and its
financiers gives rise to both moral hazard and adverse selection problems. As a result, if
commitment not a major problem, non integration may be more costly than integration.
In this section, we establish the trade-off between the benefits and costs associated with
non integration. To keep our model simple and to focus on our major contribution, we treat
the problems incurred by non integration as institutional costs in a reduced form.21 We
denote each period’s institutional cost of non integration as cN and the cost of collecting
signals in the case of integration as cI . We assume that both cN and cI are exogenously
given, and cN > cI .
According to Proposition 1, in the case of non integration, in equilibrium all bad projects
will be dropped by the entrepreneur at date 1. Moreover, for any project proposed randomly
from the project pool, with probability λ a project is a good one, generates an expected
return bV, and requires investments I1 + cN + I2 + cN ; with probability 1− λ a project is a
bad one, generates an expected return V, and requires investment I1 + cN only. Thus, the
expected profits from an externally financed project are,
πN = λ(bV − I1 − I2 − 2cN ) + (1− λ)(−I1 − cN)
= −I1 + λ(bV − I2)− (1 + λ)cN .
Using Proposition 2, in the case of integration a bad project will always be refinanced.
Given that with probability λ a project is a good one, generates an expected return bV, and
requires investments I1 + I2; and with probability (1− λ) a project is a bad one, generates
an expected return V and requires investments I1+ I2 + I3, the expected profits from an
21Following the literature of finance or theory of the firm, there are many ways to endogenize this institu-
tional cost within our framework.
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internally financed project are:
πI = −I1 − cI + λ(bV − I2) + (1− λ)(V − I2 − I3).
The difference between the profits from an internally financed project and the profits
from an externally financed project are
πI − πN = −(1− λ)(I2 + I3 − V ) + (1 + λ)cN − cI .
In contrast, it is easy to see that if liquidation does not deter an entrepreneur from
continuing a bad project at date 1, the expected payoff from non integration would be
πN = λ(bV − I1 − I2 − 2cN ) + (1− λ)(−I1 − cN ). In such a case, liquidation would not be
efficient. This is because
πI − πN = 2cN − cI + (1− λ)(V − I3) > 0.
To summarize the result, we have the following:
Corollary 2 Without a deterrent effect, liquidation alone is less efficient than reorganiza-
tion. However, with a deterrent effect, the institution which commits to liquidation can be
more efficient.
Similar to the literature on bankruptcy (e.g., Aghion, Hart, and Moore, 1992), we show
that liquidation per se can be less efficient than reorganization. But unlike the above,
we emphasize the ex-ante expectational effects of different ‘bankruptcy procedures.’ We
demonstrate that a commitment to liquidate bad projects plays a fundamental role in
deterring entrepreneurs from hiding private information. Therefore, an institution which
commits to liquidate bad projects can be more efficient.
However, even with a deterrent effect, non integration may still be less efficient than
integration. This is because the difference in the net benefits between integration and non
integration depends on the institutional cost of non integration, cN ;22 the uncertainties of
22 The institutional cost of external financing varies depending on the financial institution (examples can
be find in La Porta, Lopez de-Silanes, Shleifer, and Vishny, 1997).
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the projects, λ; the required investment in the second and third periods, I2 and I3; and
the realized value of a bad project when it is completed, V . In the following we conduct a
comparative static analysis of the difference between πI and πN .
The equation πI − πN = −(1 − λ)(I2 + I3 − V ) + (1 + λ)cN − cI shows the trade-off
between internal and non integration. On the one hand, there is a saving of investment in
a bad project under non integration, (1− λ)(I2 + I3 − V ). On the other hand, there is an
extra cost of non integration, cN (1 + λ). From this trade-off, we solve for a threshold level
λ∗ which makes πI = πN . Then we have
λ∗ =
⎧
⎨
⎩
I2+I3−(V+cN+cI)
cN+I2+I3−V , if c
N < I2 + I3 − V + cI ;
1, if cN ≥ I2 + I3 − V + cI ,
such that if λ, the probability that a project is bad, is greater than λ∗, non integration
is more efficient than integration, and vice versa. Investigating λ∗ leads to the following
lemma. It shows extreme cases where an allocation of the efficient boundary of a firm is
independent of the uncertainty of the project.
Lemma 1 If cN − cI = 0, non integration is always more efficient; if cN − cI ≥ I2+ I3−V,
integration is always more efficient; if 0 < cN − cI < I2 + I3 − V , an allocation of the
efficient boundary of a firm depends on λ.
Against the threshold level of uncertainty λ∗, it follows:
⎧
⎨
⎩
πI > πN , if λ < λ∗,
πI ≤ πN , if λ ≥ λ∗.
It is also easy to see that ∂∂λ{πI − πN} < 0. That is, the advantage of non integration
vis-a-vis that of integration increases with the uncertainty of the project type as long as non
integration is able to harden budget constraints. In the following we summarize the results
regarding the optimal strategies for carrying out a R&D project when firms face different
degrees of uncertainties and comparative static results.
Proposition 3 If 0 < cN − cI < I2 + I3 − V , there is a critical level of uncertainty of
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the project, λ∗, such that if uncertainty is low, that is, λ < λ∗, integration is more efficient
than non integration; otherwise, non integration is more efficient.
Proposition 4 If 0 < cN − cI < I2 + I3 − V , the advantage of non integration over
integration increases as
1. (a) λ increases;
(b) the institutional cost of non integration, cN , decreases;
(c) the costs of required investment at the second and third periods, I2 and I3 respec-
tively, increase; and
(d) the return from a bad project, V , decreases.
The above propositions suggest that the boundary of a firm is related to the financial
institutions and the features of R&D. The creation and development of modern financial in-
termediaries, which greatly reduce the costs of non integration, give firms broader choices to
deal with R&D projects. Venture capital financing is an example. In a financially developed
economy with low costs of non integration, to explore high uncertain R&D projects, large
firms will keep them outside. When the uncertainty decreases, large firms will bring those
projects in. As a result, high uncertain R&D projects tend to be carried out by indepen-
dent externally financed small firms; while low uncertain projects tend to be concentrated
in large firms. In contrast, in a financially underdeveloped economy with high institutional
costs of external financing, firms have no choice but to integrate, since internal financing is
always superior.
Moreover, most high-tech projects, in such fields as computers, software, bio-tech, etc.,
are characterized by high uncertainties. Thus, the concentration of venture capital financing
in high-tech industries closely matches our results.
Furthermore, when the uncertainty of a project is lower, and/or the costs of required
incremental investments decrease, and/or the final return from a bad project increases, our
results indicate that integration is more efficient. These predictions are consistent with
the observation that large corporations tend to purchase innovative projects at later stages
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when uncertainties are much lower and the returns from reorganized bad projects are not too
low. Our results thus can explain why cash-rich large corporations devote more attention to
perfection-related or cost-reduction-related innovation and less attention to new-product-
related innovation, and why corporate executives tend to restrict their R&D activities in
less uncertain and less novel projects (Scherer, 1991, 1992).
When cash-rich large corporations are interested in investing in R&D, our theory shows
that it is in their interest to co-finance such projects externally. This may help to explain
why in the 1970s IBM contracted out its first generation PC CPU chips to Intel and its
operating system to Microsoft; and why Merck did not take over one-third of the publicly
traded small bio-tech companies which produced almost ten times more new drugs than
her, while spending approximately the same amount of money for R&D.
5. CONCLUDING REMARKS
In this paper we argue that the inefficient elements in non integration, such as infor-
mational asymmetries and conflicts of interest among firms, can be strategically employed
to prevent renegotiation, and thus can help firms commit themselves to terminating bad
projects which can only be discovered ex-post. With such a credible threat, non integra-
tion may help to deter bad projects at an early stage. In contrast, if a R&D project is
internally financed, the commitment device does not exist. A disadvantage of non inte-
gration compared with integration is an extra cost caused by moral hazard and adverse
selection problems, which measure the cost of external capital markets; this is viewed as an
institutional cost.
Our theory has implications to property rights theory. Complement to the literature
about costs and benefits of ownership (e.g., Grossman and Hart, 1986; Hart and Moore,
1990), a general message of our theory is that having a full ownership over an asset may
destroy the owner’s commitment to liquidate the asset when continuing owning it would be
worse off.
Our results sheds light on the stylized fact that internally financed R&D projects by
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large companies are usually safe projects. This is because the very attractive feature of a
large company — that is, no binding financial constraints for R&D and no serious conflicts
of interest in financial decisions — prevents them from committing to an efficient ex-post
selection of projects. Indeed, this insight is consistent with empirical studies which show
that large corporations have a tendency to maintain the stability of their R&D organization;
moreover, their R&D budgeting is usually not based on individual projects, which implies
a smoothing of revenue across projects (Mansfield, 1968, p.62, and Reeves, 1958). It also
sheds light on syndicated financing, and helps to understand the paramount importance of
such a financial phenomena from a theoretical perspective.
Our theory is complement to another strand of literature on R&D financing and the
boundary of the firm that studies the issue from the perspective of knowledge transfer and
tries to make knowledge transfer possible. Our theory provides a complementary theoretical
answer, which argues that an informational asymmetry between co-financiers that prevents
a knowledge transfer can actually bring in benefits to financiers, because if used wisely, the
difficulty in knowledge transfer can stop bad R&D investment promptly.
Our results also have important implications for centralized economies. With the whole
economy is integrated, in centralized economies R&D projects are always financed internally.
Moreover, we show that the optimal financing strategy for less uncertain R&D projects, such
as in machine building, chemicals, steel, and other heavy industries, is to finance projects
internally. Thus we predict that there should be no substantial difference in R&D in
those industries between a decentralized economy and a centralized economy. In reality,
centralized economies indeed perform reasonably well in R&D for those industries.
In high-tech industries, such as computers, electronics, or bio-tech, where R&D projects
can be very uncertain,23 however, non integration is more efficient. A high degree of integra-
tion in a centralized economy implies serious inefficiencies for R&D projects in these areas
due to the lack of an ex-post screening mechanism. In fact, the most striking examples to
support our insight are the devastating failures of serious efforts on the part of the Soviet
23Most of the basic scientific principles for computers, integrated circuits, and bio-tech were developed
parallel to R&D projects in those fields. This made the uncertainty of such projects very high.
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Union to catch up with the West in computers and electronics, despite their strategic and
military importance.
Our theory has implications for economic growth. The central role of financial institutions
on technological change on economic growth has been recognized since Schumpeter (1934).
In the new growth theory, the role of R&D in growth is endogenized through inputs to
technological change and knowledge accumulation while the role of financial institutions
are ignored. Nevertheless, we observe financial institutions playing important roles to affect
the efficiency of R&D and growth. Our theory has implications to the role of financial
institutions on growth (Huang and Xu, 1999).
For firms in catching-up economies, imitating or perfecting existing technologies are the
best strategies. With the low uncertainty of imitation, our theory implies that single
financier financing is more efficient for work on catching-up projects. Thus, financial
institutions which make internal financing R&D easier can greatly accelerate the catching-
up process, such as in Japan in the 1960s to the early 1980s, and in South Korea and in
other East Asian economies in the 1980s and the 1990s. However, high-tech firms in the
most advanced economies face frontiers of technological innovation which are associated
with high uncertainties. Our theory predicts that multi-financier financing should be more
efficient, but low institutional costs for multi-financier financing are critical. Venture capital
institutions may be one such institution to reduce these costs. In contrast, some of those
financial institutions which are efficient in financing catching-up (imitation or perfection)
projects may not be efficient in financing technologically more advanced projects. Huang
and Xu (1999) develop a theory to examine how financial institutions affect technological
innovation and thus affect growth. In their model economic growth is affected by the
efficiency and riskiness of R&D which are endogenized through financial institutions that
generate hard- or soft-budget constraints.
Moreover, our theory provides a novel way to understand financial crisis from an insti-
tutional perspective (Huang and Xu, 1998). Due to the adverse effects of the soft budget
constraint associated with project uncertainties, bad projects do not stop, and bad loans
accumulate. Moreover, bank lending to bad projects is always justified. Therefore, the pre-
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vailing soft budgeting in an economy distorts information, such that the inter-bank lending
market faces a “lemon” problem. If we suppose that the availability of information about
bank project quality is critical for the operation of the financial market to provide loans
to illiquid banks, the lemon problem in the lending market may contribute to bank run
contagions and may lead to the collapse of the lending market and induce a run on the
economy. In contrast, an economy with a predominance of hard budget constraints has
mechanisms which allow information to be disclosed timely from the firms to the banks,
and to the financial market. Thus bank runs can be stopped, contagious risks contained,
and financial crisis prevented. Moreover, Huang and Xu (1998a) show the tragedy of a
‘soft-budget constraint trap’ in an SBC economy. That is, due to the lemon problem in
the financial system, without changing the institution in a fundamental way, the best a
government can do in an SBC economy is to bail out all the illiquid banks.
Finally, some remarks about our approach are in order. In order to keep our model simple,
we have chosen to use a reduced form of the institutional cost of non integration, which is
a measurement of the imperfection of capital market. It is related to another dimension
of the informational asymmetry between the financiers and the entrepreneur which may
result in moral hazard and adverse selection problems for the entrepreneur. Depending
on capital market development and other institutional settings, such as the legal system,
the institutional cost may vary across countries and over time (La Porta, et al, 1997).
There exists extensive economic and finance literature which provides the rationale for such
institutional costs (e.g., Arrow, 1962; Stiglitz and Weiss, 1981; and Myers and Majluf,
1984). Thus, it is not difficult to develop a model with fully endogenized institutional costs
with richer results.
With respect to our reduced form treatment of the entrepreneurs’ private benefits, it
should be pointed out that this can be replaced by endogenized compensations to the
entrepreneur and all of the above results will not be changed qualitatively.
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